Panel: Utilizing a Device Platform Technology across Multiple Therapeutic Categories

Most pharma and biotech companies realize the need and benefit of having a platform device technology. The challenge then becomes figuring out how to utilize the device to deliver different types of drugs for various indications such as rheumatoid arthritis, cancer, and rare diseases.

Moderator: Paul Jansen

Former Associate VP Sanofi and Board Member and Senior Advisor, Haselmeier

Panelists: Donna French, PhD

VP Drug Delivery and Device Development, MedImmune

Michael Graffeo, MBA

VP Business Development, Drug Delivery Insulet

Rajan Patel

CEO, io Life science

Srini Sridharan, PhD

Group Director, Materials Science and Engineering, BMS